EPH21 Risk of Incident Cardiovascular Events with Disease-Modifying Antirheumatic Drugs Combinations Among Adult Patients with Rheumatoid Arthritis: A Nested Case-Control Study

Y. Huang,S. Agarwal, S. Chatterjee,H. Chen,M.L. Johnson,R.R. Aparasu

Value in Health（2023）

引用 0|浏览0

暂无评分

摘要

Disease-modifying antirheumatic drugs (DMARDs) are the cornerstone of rheumatoid arthritis (RA) treatment. DMARDs targeting inflammation for disease control could reduce cardiovascular (CV) risk; however, each DMARD class with unique mechanistic pathways may have differential CV risk. This study examined the risk of CV disease (CV) associated with DMARDs in RA.

查看译文

关键词

antirheumatic drugs combinations,rheumatoid arthritis,incident cardiovascular events,disease-modifying,case-control

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要